ABOUT ISODIOL INTERNATIONAL

keyboard_arrow_down

OUR MISSION

To develop over-the-counter and pharmaceutical drugs utilizing our phytoceutical portfolio and aggressively continue international expansion into Latin America, Asia and Europe.

LEADERSHIP

Isodiol’s leadership team manages a growing global wellness company and are the visionaries behind some of the most respected brands in the Cannabis industry. Their strategic direction for Isodiol International focuses on generating the highest quality phytoceutical consumer products and fostering innovation in pharmaceutical grade compound, while expanding into new markets around the world.

MANAGEMENT TEAM

Marcos Agramont

CEO, DIRECTOR

Troy Nihart

PRESIDENT ISO INTERNATIONAL, LLC

Bryan Loree

CFO, DIRECTOR

Troy Dooly

COO ISO INTERNATIONAL, LLC

Daniel Zuckerman

VP IsoBev

Jared Berry

FOUNDER

Aman Parmar

CHAIRMAN

Soheil Samimi

DIRECTOR

Gary Plichta

ADVISER

Clay Kahler

ADVISER

OUR BUSINESS

Isodiol International, Inc., together with its subsidiaries and affiliates, is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.

OUR BUSINESS

Isodiol is the trusted producer of raw ingredients, consumer packaged goods such as dietary supplements, food & beverages, skin care, and pharmaceutical products for the international healthcare market.

RAW INGREDIENTS

Isodiol develops natural phytoceutical derivatives and delivery technologies. We sell these in bulk to the worldwide market for formulation.

CONSUMER PRODUCTS

Isodiol develops its own family of product brands for retail sale as well as white label products & brands for wholesale customers.

PHARMACEUTICALS

In addition to the development of its own products, Isodiol supplies raw phytoceutical raw ingredients to pharmaceutical companies in the process of research, clinical trials, and/or product roll-out.

OUR FAMILY OF BRANDS

isodiol.com logo
iso-sport.com logo
cbdxtreme.com logo
cbdskincream.com logo
 pot-o-coffee logo

HISTORY OF ISODIOL

2009

Naturally derived Cannabidiol from Industrial Hemp was discovered for the worldwide market

'09-11

Executed two years of government contracts to grow and extract from Hemp

2011

ISO99 Developed: An isolated ≥99% pure, dry form of refined Hemp oil

2012

Cebediol(TM) Developed: Micro-encapsulation used on Anhydrous Hemp Oil

'13-15

Two years of clinical studies performed

2014

NanoUltra(TM) Created: Nanoemulsified Anhydrous Hemp Oil suspended in water for use in food & bev

2015

HenePlex(TM) Created: Full spectrum nanoemulsified phytocannabinoid complex

2015

Developed OTC compliant topical pain cream

2016

Finished goods consumer brands developed for nutraceutical division

2017

Isodiol International becomes a publicly traded entity in Canada under the CSE symbol: ISOL

INVESTOR RELATIONS

CONTACT

Isodiol International, Inc
1212 Austin Ave
Coquitlam, BC V3J 5E7
Canada

+1-604-409-4409
ir@isodiol.com

CEO: Marcos Agramont

TRANSFER AGENT

Computershare Investor Services Inc.

STOCK EXCHANGE

Canada CSE: ISOL
USA OTC: ISOLF
Frankfurt: LB6A.F

Industry Classification:
Diversified

Reporting Jurisdictions:
British Columbia
Alberta
Ontario

Short Form Prospectus Issuer: No

REGULATORY

Principal Regulator: British Columbia

Date of Formation: June 2, 2014

Jurisdiction Where Formed: British Columbia

Financial Year End: Mar 31

CUSIP Number: 465400L101

Auditor: Charlton & Company

Facebook Twitter Instagram
Show Floating Cart